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Wound healing with honey - a randomised controlled trial 
Ronald Ingle, Jonathan Levin, Krijn Polinder 
Objectives. To compare honey and IntraSite Gel as wound-
healing agents, to record side-effects, gauge patient satisfaction 
and calculate the cost-effectiveness of the honey used. 
Design and setting. A prospective, randomised, double-blind 
controlled trial was carried out among goldmine workers. 
Outcome measures. Outcome measures were healing times of 
shallow wounds and abrasions; side-effects; patient satisfaction 
with treatment; and amount of honey and IntraSite Gel used. 
Results. The mean healing times of shallow wounds treated 
with honey or with IntraSite Gel did not differ significantly 
(p = 0.75, 95% confidence interval (CI): -5.41; 7.49 days). When 
adjusted for wound size, the 2.8-day difference in favour of 
honey was not significant (p == 0.21, 95% CI: -2.41; 8.09). In the 
case of abrasions there was also no significant difference 
(p = 0.83, 95% CI: -4.98; 6.19 days). When adjusted for wound 
size, the difference of 0.22 days in favour of IntraSite Gel was 
The study was conducted in 1996. Since then great advances 
have been made with regard to understanding the healing 
properties of honey, how to use it, and the development and 
availability of honey products. 'Honey, the most ancient of 
wound treatments, is taking its place in modern wound care 
... it is easy to apply, painless and comfortable, harmless to 
tissues, creates a moist healing environment, is antibacterial 
and stimulates healing and epithelialisation.'1 Some of honey's 
antibacterial activity is due to the high osmolarity created by 
its sugar content, some is due to hydrogen peroxide released 
by exudate, and some is due to phytochemicals that come from 
the nectar of plants.1 The latter are so important a factor in 
Manuka honey (from Leptospermum scoparium) that this activity 
is measured as the 'Unique Manuka Factor' (UMF number).1 
In vitro and animal studies2·4 have also advanced our 
knowledge of honey's properties of moisture retention, 
antimicrobial and angiogenetic activity, and granulation tissue 
formation and epithelialisation. 
As honey becomes accepted in mainline wound care, concerns 
about potency, sterility, and contamination from its natural 
sources have led to standardisation, regulation and licensing. 
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not significant (p = 0.94, 95% CI: -5.72; 6.15.4). Of patients 
treated with honey, 27% and 10% respectively experienced 
itching and pain, and 2 experienced burning for a short time 
after application. Of patients treated with IntraSite Gel, 31% 
experienced itching. All patients in both treatment groups 
were either satisfied or extremely satisfied with treatment. The 
average cost of treatment per patient was R0.49 with honey and 
R12.03 with with IntraSite Gel. 
Conclusions. A distinction should be made between shallow 
wounds and abrasions when wound healing is being measured. 
There was no evidence of a real difference between honey 
and IntraSite Gel as healing agents. Honey is a safe, satisfying 
and effective healing agent. Natural honey is extremely cost-
effective. 
S Afr Med J 2006; 96: 831-835. 
It is unfortunate in some ways that such stringency means 
that honey 'off the shelf' may not be acceptable. The European 
Union requires honey products sold in Europe to meet essential 
health and safety requirements and to be CE (Conformite 
Europeenne)-marked.5 
The way in which honey is applied and the materials used as 
wound dressings make a difference. Wound exudates can either 
activate or dilute some of the healing properties. This has led to 
commercial products that incorporate honey in substrates such 
as hydrocolloids and hydrogels.1 
Finally, honey scores in terms of the 'aesthetics' and 
prejudices of wound care! Honey-impregnated dressings 
deal with its perceived 'messiness', and honey 'cleans' and 
deodorises offensive wounds.1'6 
In the developing world a reluctance to stay with simple and 
still effective methods, treatments and equipment, in order to 
'catch up' with the developed world, comes at a cost. Postmes 
and Vandeputte7 suggest that honey be used instead of high-
tech products such as the new recombinant growth factors. As 
far as we can tell, no literature refers to the cost-effectiveness of 
honey in wound management. This may receive low priority 




The study aimed: (i) to compare wound healing using natural 
honey and IntraSite Gel as healing agents; (ii) to record side-
1m 
effects; (iii) to gauge patient satisfaction; and (iv) to calculate the 
cost-effectiveness of the honey used. 
Design and setting 
A prospective, randomised, double-blind controlled trial was 
carried out by one of the authors (KP) at Randfontein Estates 
Gold Mining and Westonaria Gold Mining from September 
1995 to July 1996. Patients were mineworkers. 
Eligible patients 
Those with shallow wounds not deeper than 2 em and not 
larger than 100 cm2 or with abrasions between 10 and 100 cm2 in 
size, which included donor sites for skin grafting and partial-
thickness burns, were included in the study. The presence 
of slough (which term will hereafter include descriptions of 
necrosis) was recorded. 
Excluded patients 
Those unwilling to be tested for HIV or with underlying or 
surrounding wound infection, genital or malignant ulcers, 
wounds of the legs, perineum, fingers or toes (making wound 
measurement difficult), systemic disease or chronic alcoholism 
were excluded from the study. 
Estimation of study group size 
The required size calculated for each group to detect a 
difference between mean healing times of 5 days was at least 
40 patients, using an a-value of 0.05, power of 80%, and a 
standard deviation (SD) of 8 days. 
Stratified randomisation 
Enrolled subjects were stratified by wound type, HIV status 
and the presence of slough, then randomised (using random 
permuted blocks of size 10) to treatment with either honey or 
IntraSite Gel to produce approximately equal numbers in each 
treatment group and an approximate balance of the 3 possible 
prognostic factors (Table I). 
Other characteristics recorded 
Other characteristics recorded were initial wound size, age, 
body mass index, systolic and diastolic blood pressure, and 
smoking history. 
Outcome measures 
Healing time. Healing time was considered to be the number of 
days elapsed before the predetermined endpoint was reached of 
3 cm2 for shallow wounds, or full epithelialisation for abrasions. 
The 3 cm2 endpoint was chosen so that inpatient care was not 
prolonged only for the sake of reliable study supervision. 
Side-effects. Side-effects measured were pain, burning 
sensation, itching, allergic reaction, or any other reaction 
specifically mentioned. 
Patient satisfaction with treatment. On the 7th day of 
treatment, or earlier if healing time was less, the patient was 
asked to say whether he was very dissatisfied, dissatisfied, 
satisfied, or very satisfied with treatment, or whether he could 
not say. 
Amount of honey and IntraSite Gel used. This was 
measured per patient in grams. 
Healing agents 
The two agents evaluated were natural monofloral aloe 
honey, creamed by crushing and not heated, and IntraSite 
Gel, a hydrogel wound-care product manufactured by Smith 
and Nephew Ltd. consisting of propylene glycol20%, starch 
copolymer 2% and water 78%. 
Wound management 
All wounds were cleaned once daily with normal saline. Honey 
was then applied with a prepacked wooden spatula, using a 
fresh spatula for each application. IntraSite Gel was expressed 
from sterile sachets. The amounts applied depended on the 
size of the wound. All wounds were covered with Opsite to 
keep the agent in place. Patients did not know which agent was 
being used. All patients' diets were supplemented with zinc 
sulphate and vitamins A, B and C. 
Wound evaluation 
KP evaluated each wound on the day of entry to the trial, 
without knowing which agent would be applied. When the 
healing endpoint was approaching he measured the surface 
area daily, still blinded, the applied agent from the previous day 
having been washed off with normal saline. 
Table I. Wound types randomised by block for treatment with honey or IntraSite Gel (withdrawn from analysis)* 
HIV-negative HIV-positive 
Slought + Sloug:h-
Wound type Honey IntraSite Gel Honey IntraSite Gel 
Shallow wound 10 7 (1) 10 (3) 10 
Abrasion 5 (1) 6 6 5 
Subjects enrolled 16 14 19 15 
Final study group 15 13 16 15 
*Total number of enrolled subjects~ 87 (honey group N ~ 44, lntraSite Gel group N ~ 43). 
Total number in final study group ~ 82 (honey group N ~ 40, lntraSite Gel group N ~ 42). 
t The term 'slough1 here includes recorded descriptions of necrosis. 
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Slough+ Slough-
Honey IntraSite Gel Honey IntraSite Gel 
3 4 2 4 
0 1 4 5 
3 5 6 9 
3 5 6 9 
Wound measurement 
Transparent Opsite Flexigrid films (Smith and Nephew Ltd.) 
with 5 mm squares were used to trace the wound outlines. 
Squares were counted, and quarters of squares estimated 
as 6 mm2. Partial-thickness burns and abrasions were not 
measured again because full epithelialisation was their healing 
endpoint. 
Ethics 
It was known that both agents were without serious side-effects 
and that neither was absolutely superior as treatment. With the 
help of an interpreter, KP did his best to explain randomisation 
and blinding to the patients. Consent to take part in the trial 
and to be tested for HIV were recorded on a consent form. 
Analysis 
Analysis of covariance was used to compare the healing times 
of the treatment agents in order to allow adjustment for wound 
size, wound type, HIV status and the presence of slough. This 
showed overwhelming evidence of a wound type/wound 
size interaction (effect modification), but no evidence of any 
other interaction. Hence comparison of healing times between 
treatment groups was carried out separately for each wound 
type and analysis of covariance again used to make the above 
adjustments. 
Cost-effectiveness was calculated as the average cost per 
patient of all the honey used divided by the average cost of all 
the IntraSite Gel used, expressed as a percentage. 
Results 
Of 87 patients enrolled, 5 were excluded from the analysis: 
1 wound was misjudged as being an abrasion but there was 
complete skin loss, 1 was misjudged as being a shallow wound 
but there were islands of healing, 1 patient withdrew after 2 
days for personal reasons, and 2 wounds were dressed with 
both agents in error. Forty wounds were treated with honey, 
of which 25 were shallow wounds and 15 were abrasions 
or partial-thickness burns. Forty-two wounds were treated 
with IntraSite Gel, of which 25 were shallow wounds and 17 
were abrasions, donor sites or partial-thickness burns. The 
composition of the groups did not differ significantly in terms 
of recorded characteristics (Table II). 
Table II. Treatment groups compared (standard deviation) 
Mean age (years) 
Mean body mass index 
Mean systolic BP 
Means diastolic BP 
Never smoked (N (%)) 
HIV-positive (N (%)) 
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Honey group 







The mean healing times for all shallow wounds and all 
abrasions were 16.6 days (SD 11.23) and 16.81 days (SD 7.67) 
respectively. 
The rnean wound sizes for all shallow wounds and all 
abrasions were 786 mm2 and 3 868 mm2 respectively. The 
difference of 3 082 mm2 was significant (95% confidence interval 
(CI): -3 873; -2 292). The difference in the range of wound 
sizes (shallow wounds 1 450 mm2, abrasions 8 920 mm2) was 
considerable (Fig. 1). 
Analysis of covariance showed that in the case of shallow 
wounds there was a highly significant effect of wound size on 
healing time (p < 0.001), but in the case of abrasions there was 
no such significant effect (p = 0.24). 
Shallow wounds 
Analysis by 2-sample t-test found no significant difference in 
mean healing time between those treated with honey (N = 25, 
16.08 days) and with IntraSite Gel (N = 25, 17.12 days) (p = 0.75, 
95% CI: -5.41; 7.49) (Fig. 2 and Table III). Analysis of covariance, 
adjusting for wound size, HIV status and slough, also showed 
no evidence of a significant difference (p = 0.28). The estimated 
difference was 2.84 days in favour of honey (95% CI: -2.41; 8.09). 
Abrasions 
Analysis by 2-sample 1-test found no significant difference 
in mean healing time between those treated with honey 
(N = 15; 17.13 days) and with IntraSite Gel (N = 17, 16.53 days) 
(p = 0.83, 95% CI: -4.98; 6.19) (Fig. 3 and Table III). Analysis of 
covariance, adjusting for wound size, HIV status and presence 
of slough, also showed no evidence of a significant difference 
(p = 0.94). The estimated difference was 0.22 days in favour of 
the gel (95% CI: -5.72; 6.15). 
There was evidence that the distribution of healing times was 
skewed to the right (slower healing), particularly in the case 
of shallow wounds. However the 2-sample t-test is robust to 
moderate departures from normality. To test the effect of this 
assumption separate analyses, using log transformations of 
healing times and also non-parametric (Mann-Whitney) tests, 
gave similar results. 
The side-effect of itching was mentioned by 27% of the honey 
group and 31% of the IntraSite Gel group. ln the honey group 
10% of patients complained of pain and 2 patients experienced 
lntraSite Gel group 
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Fig. 2. Box plot of healing time (days) for shallow wounds by agent. 
a burning sensation for a short time after application. No 
patient asked for treatment with either agent to be stopped. 
There was no significant difference between patient 
satisfaction in the 2 treatment groups. Twenty-two per cent 
and 78% of patients in the honey group were satisfied or very 
satisfied respectively. The proportions in the IntraSite Gel group 
were 29% and 71%. 
The average cost of the use of honey was 4% that of Intrasite 
Gel (Table IV). 
Discussion 
Most studies of honey's healing effects have been observational. 
mJ There are few randomised controlled trials in a clinical setting. 
Subrahmanyam's several studies8•11 were of patients with burns 
of varying degrees, among whom the measurement in days of 
'complete healing' was often complicated by overgranulation. 
Sometimes 'signs of healing' were compared. 
We suggest that it is a strength of this study of comparative 
healing powers that the wounds studied were small enough to 
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min-[ mean± 95% confidence interval]- max 
Fig. 3. Box plot of healing time (days) of abrasions by agent. 
Table III. Mean healing times (days) with honey or 





16.08 (12.3- 19.9) 
17.12 (11.7- 22.5) 
Abrasions 
17.13 (13.1 - 21.1) 
16.53 (12.3- 20.8) 
dress in a standard way, were primarily uninfected and did not 
include chronic, non-healing wounds. 
The antibacterial potency of different natural honeys can vary 
up to a 100-foldY Monofloral aloe honey was used. To justify 
this identification we relied on the advice of an experienced 
beekeeper that bees focus on abundantly flowering aloes at a 
time when other species are scarcely flowering. 
The antimicrobial and healing properties of honey are 
distinguishable. Healing was therefore compared in non-
infected wounds. Apart from ethical considerations, we did not 
include an untreated control group because the positive healing 
properties of honey have been demonstrated in animal studies.2 
Diets of both groups were supplemented with zinc 
sulphate and vitamins A, Band C to obviate the possibility of 
compromising deficiencies. Since then no evidence of benefit 
has been found in studies of zinc and the healing of leg ulcers, 
but inadequate zinc intakes are prevalent in southern Africa.13"4 
No evidence has been found for the effectiveness of oral 
multivitamin supplementation, including vitamin C, on ulcer 
healing. 15 
The only references we found in the literature of clinical trials 
to the measurement of healing refer to 'signs of healing' or 
'complete healing'. A statistical analysis reported to compare 
the rates of wound healing, in fact compared healing time in 
days.10 We abandoned healing rate (wound size/healing time) 
as a comparative measure. 
While the healing process involves many tissues, the only 
observable part is epithelialisation and its completion. The 
ORIGINAL ARTICLES 
Table IV. Cost of agents used 
Average used 
per patient (g) 
Purchase price 
(R/g) Cost/g (R) 








study measured the time in days to reach defined endpoints of 
such wound closure. Abrasions or partial-thickness burns may 
include islets of epithelial cells, so that epithelialisation might 
proceed 'multi-marginally' from many margins within the 
boundary of the lesion, compared with 'uni-marginal' healing 
from the one boundary of a shallow wound. Initial wound size, 
more obviously, affects the duration of epithelialisation and, 
although measured, was not allowed for by stratification. The 
argument on which our analysis is based was as follows. 
Preliminary analyses showed correlation between the size 
and healing time of shallow wounds, but no such correlation 
for abrasions. This seemed to support the thesis that abrasions 
heal 'multi-marginally' whereas shallow wounds heal 'uni-
marginally'. Because their healing processes were in some 
way different, we decided to separate the wound types for 
comparative purposes. 
It is important to recall that the study was designed with 
a discriminating difference in healing time of 5 days. Non-
inferiority study designs were generally not used at the time of 
the study. 
Conclusions 
When analysing wound healing, shallow wounds and 
abrasions should be separated. The worst-case scenario for 
honey, considering confidence intervals, was inferiority by 2.4 
days for shallow wounds, and 6.2 days for abrasions. Best-case 
scenarios favour honey by 8.1 days for shallow wounds and 
5.7 days for abrasions. This is not evidence of a real difference 
between honey and IntraSite Gel as healing agents. 





That honey is a safe, satisfying and effective healing agent 
is confirmed. That it was comparably effective in the study 
allows the important conclusion that, in a natural form, honey 
is extremely cost-effective. 
This research comprised K Polinder's dissertation for the 
MFamMcd degree at the Medical University of Southern Africa. 
References 
1. Molan PC, Betts JA. Clinical usage of honey as a wound dressing: an update. Journal of 
Wound Care 2004; 13: 353-356. 
2. Bergman A, YanRi J, Weiss L Bell D, David MP. Acceleration of wound hcnling by topicol 
application of honey. An animal model. Am j Surg 1983; 145: 374-376. 
3. Cooper RA, MQ!an PC, Harding KG. Antibacterial activity of honey against strains of 
Slnphylococws nun'llS from infected wounds. J R Soc Mcd 1999; 92:283-285. 
4. Allen KL, Molan PC, Reid GM. A surV('Y of the antibacterial activity of some New Zealand 
hont•ys.] Pharm Plwrmaco/1991; 43:817-822. 
5. Postmes T, van den Bogaard AE, Hazen M. Honey for wounds, ulcers, and skin graft 
preservation. (Letter). Lancet 1993; 341: 756-757. 
6. Ahmed AK, Hoekstra MJ, Hagc JJ, Karim RB. Honey-medicated dressings: transformation of 
an ancient remedy into modern theri1py. Ann P/ast Surg 2003; SO: 143-147. 
7. Postmes T, Vnndeputtc J (Letter). Recombinant growth factors or honey? Bums 1999; 25:676-
678. 
8. Subrahmanyam M. Topical application of honey in treatment of burns. Br j Surg 1991; 78: 
497-498. 
9. Subrahmanyam M. Honey impregnated gauze versus polyurethane film (OpSite®) in the 
treatment of burns- a prospective randomised study. Br J Plast Surg 1993; 46: 322-323. 
10. Subrahmonyam M. A prospective randomised clinical and histological study of superficial 
burn wound healing with honey and silver sulphadiazine. Burns '1998; 24: 157-161. 
11. Subrahmanyam. M. Effects of topica.l application of honey on burn wound heoling. Annals of 
Rums a11ri Fire Disasters 2001; XIV: 143-145. 
12. Molan PC. Thf.:' a.ntibactcria.l activity of honey. 2. Variation in potency of the antibacterial 
a.ctivity. Bee World 1992; 73:59-76. 
13. Wilkinson EAJ, Hawke Cf. Docs ora. t zinc aid healing in chronic leg ulcers? !lrch Derma to! 
1998; 134:15.%-1560. 
14. Caulfield LE, Black HE. Zinc denciency. In: Ezzati M? Lopez A? Rodgers A, Murray CLJ, cds. 
Comparative Risks. Global and Regional Burden of Disease Attributable to 
Selected Mnjor World Health Organization, 2002. 
15. Gray M, Whitney JD. Does oral supplementation with vitamins A or E 
chronic wounds? Journal of Wound, Q.,;;fomy tmd 
Accepted 13 December 2005. 
